Critical targets such as TNF, EGFR, ESR1, HIF1A, HSP90AA1, and SRC were involved in pathways including chemical carcinogenesis, PI3K‐Akt signaling, proteoglycans in cancer, receptor activation in chemical carcinogenesis, and immunomodulation. This evidence concerns the gene EGFR and cancer.